Home
Conditions
Pemphigus

Clinical trial condition

Pemphigus

Explore clinical trials studying Pemphigus. Study availability and eligibility vary by location and protocol.

41 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Pemphigus trial results

Completed

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

NCT00960713

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +21 more
Locations: Service de médecine interne, hôpital Purpan, place du Dr Baylac Toulouse, France

View Trial Details

Completed

Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab

NCT01299857

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +3 more
Locations: UH-Rouen Rouen, Seine maritime,, France

View Trial Details

Completed

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)

NCT00683930

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: Los Angeles, California, United States

Atlanta, Georgia, United States

Baltimore, Maryland, United States

St Louis, Missouri, United States

View all 26 locations

View Trial Details

Completed

Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone

NCT00626678

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: Department of Dermatology, Tehran University of Medical Sciences Tehran, Tehran Province, Iran

View Trial Details

Completed

Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

NCT00010413

Conditions: Autoimmune Diseases, Communicable Diseases, Disease Attributes, +9 more
Locations: Johns Hopkins University School of Medicine Baltimore, Maryland, United States

View Trial Details

Completed

Use of KC706 for the Treatment of Pemphigus Vulgaris

NCT00606749

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: Victoria Werth, MD Philadelphia, Pennsylvania, United States

View Trial Details

Completed

European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus

NCT00127764

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +3 more
Locations: Department of Dermatology, University Medical Center Groningen Groningen, Netherlands

View Trial Details

Completed

Safety Study of PI-0824 to Treat Pemphigus Vulgaris

NCT00063752

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: University of California San Francisco San Francisco, California, United States

Johns Hopkins School of Medicine Baltimore, Maryland, United States

East Coast Clinical Research Salisbury, Massachusetts, United States

Stony Brook Dermatology Associates East Setauket, New York, United States

View Trial Details

Active, Not Recruiting

ONO-4059 Study in Patients With Steroid-resistant Pemphigus

NCT06696716

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: Ichinomiya Municipal Hospital Aichi, Japan

Nagoya City University Hospital Aichi, Japan

Ehime University Hospital Ehime, Japan

Kurume University Hospital Fukuoka, Japan

View all 25 locations

View Trial Details

Active, Not Recruiting

IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus

NCT04400994

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +3 more
Locations: Department of Medicine Central, Hong Kong

View Trial Details

Pemphigus

Pemphigus trial results

Related conditions